ES2173739T3 - Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion. - Google Patents

Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion.

Info

Publication number
ES2173739T3
ES2173739T3 ES99920897T ES99920897T ES2173739T3 ES 2173739 T3 ES2173739 T3 ES 2173739T3 ES 99920897 T ES99920897 T ES 99920897T ES 99920897 T ES99920897 T ES 99920897T ES 2173739 T3 ES2173739 T3 ES 2173739T3
Authority
ES
Spain
Prior art keywords
pharmaceutical form
multiparticular
pulsed release
programmed
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99920897T
Other languages
English (en)
Spanish (es)
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Prographarm SA
Original Assignee
Laboratories Prographarm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Prographarm SA filed Critical Laboratories Prographarm SA
Application granted granted Critical
Publication of ES2173739T3 publication Critical patent/ES2173739T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES99920897T 1998-05-20 1999-05-20 Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion. Expired - Lifetime ES2173739T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (1)

Publication Number Publication Date
ES2173739T3 true ES2173739T3 (es) 2002-10-16

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99920897T Expired - Lifetime ES2173739T3 (es) 1998-05-20 1999-05-20 Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion.

Country Status (24)

Country Link
EP (1) EP1077687B1 (enExample)
JP (1) JP2002515423A (enExample)
KR (1) KR100583065B1 (enExample)
CN (1) CN1186014C (enExample)
AT (1) ATE214598T1 (enExample)
AU (1) AU758299B2 (enExample)
BG (1) BG64764B1 (enExample)
BR (1) BR9910606A (enExample)
CA (1) CA2333188C (enExample)
DE (1) DE69901062T2 (enExample)
DK (1) DK1077687T3 (enExample)
ES (1) ES2173739T3 (enExample)
FR (1) FR2778848B1 (enExample)
GE (1) GEP20022750B (enExample)
HU (1) HU224193B1 (enExample)
IL (1) IL139774A (enExample)
MX (1) MXPA00011364A (enExample)
NO (1) NO330501B1 (enExample)
NZ (1) NZ508392A (enExample)
PL (1) PL192950B1 (enExample)
PT (1) PT1077687E (enExample)
TR (1) TR200100107T2 (enExample)
WO (1) WO1999059557A1 (enExample)
ZA (1) ZA200006768B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
ATE214598T1 (de) 2002-04-15
BG104963A (en) 2001-07-31
DK1077687T3 (da) 2002-06-17
FR2778848A1 (fr) 1999-11-26
MXPA00011364A (es) 2008-09-09
NO330501B1 (no) 2011-05-02
HUP0102027A2 (hu) 2002-03-28
AU3830299A (en) 1999-12-06
JP2002515423A (ja) 2002-05-28
DE69901062T2 (de) 2002-10-31
GEP20022750B (en) 2002-08-26
TR200100107T2 (tr) 2001-06-21
KR20010052370A (ko) 2001-06-25
HU224193B1 (hu) 2005-06-28
IL139774A0 (en) 2002-02-10
BG64764B1 (bg) 2006-03-31
AU758299B2 (en) 2003-03-20
CN1186014C (zh) 2005-01-26
HUP0102027A3 (en) 2002-12-28
NZ508392A (en) 2002-09-27
PL192950B1 (pl) 2006-12-29
PL344314A1 (en) 2001-10-22
FR2778848B1 (fr) 2001-11-23
IL139774A (en) 2005-09-25
KR100583065B1 (ko) 2006-06-08
BR9910606A (pt) 2001-10-02
EP1077687B1 (fr) 2002-03-20
DE69901062D1 (de) 2002-04-25
ZA200006768B (en) 2001-11-20
CA2333188C (fr) 2010-07-06
NO20005838D0 (no) 2000-11-17
NO20005838L (no) 2001-01-10
CA2333188A1 (fr) 1999-11-25
HK1033271A1 (en) 2001-08-24
WO1999059557A1 (fr) 1999-11-25
CN1305371A (zh) 2001-07-25
PT1077687E (pt) 2002-09-30
EP1077687A1 (fr) 2001-02-28

Similar Documents

Publication Publication Date Title
ES2173739T3 (es) Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion.
ES8609374A1 (es) Copolimeros anfipaticos biodegradables
CY1105051T1 (el) Παρασκευασμα σε μορφη υμενιου για τη διφασικη απελευθερωση ουσιων με φαρμακολογικη δραση ή αλλων ουσιων
CY1119831T1 (el) Αποτρεπτικα της καταχρησης σκευασματα φαρμακων
BR0107874A (pt) Implante farmacêutico para controlavelmente liberar uma droga, método para controlavelmente liberar uma droga em um indivìduo, e, método para preparar o implante
TR199701083T1 (xx) Transdermal uygulama i�in farmas�tik kompozisyon.
DE69940735D1 (de) Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
DE60041978D1 (de) Auf äussere bedingungen ansprechende polymere hohle partikel
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
WO1998029095A3 (en) Sustained release cisapride mini-tablet formulation
Shen et al. Tetracycline release from tripolyphosphate–chitosan cross‐linked sponge: a preliminary in vitro study
DE60232147D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure-glycolsäure copolymer, und verfahren zu deren herstellung
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
DE60334388D1 (de) Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung
DZ3473A1 (fr) Formulation pharmaceutique a liberation prolongee independante de la force ionique.
Aher et al. Bilayered films based on novel polymer derivative for improved ocular therapy of gatifloxacin
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
DE60017444D1 (de) Pharmazeutische formulierungen auf basis fester dispersionen
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
DE69900690D1 (de) Hypoosmotische salzlösungen, verfahren zu ihrer herstellung und pharmazeutischer präparate auf basis dieser lösungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1077687

Country of ref document: ES